Evidence mapPaperPMID 41971016Full record

ReviewGenes & diseases2026

Role of circular RNAs in regulating toxicity induced by cancer therapies.

Jiawen Xian, Javeria Qadir, Burton B Yang, Ting Ye

Abstract readReview
In one paragraph

Review in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiawen XianDepartment of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
Javeria QadirDepartment of Biosciences, COMSATS University Islamabad, Islamabad 444000, Pakistan.
Burton B YangSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
Ting YeDepartment of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to transformative improvements in diagnosis and treatment, survival rates for cancer patients have improved significantly across the globe. However, toxicity induced by oncotherapy remains a major concern and markedly affects disease prognosis. In recent years, research on the association between circular RNAs (circRNAs) and oncotherapy-induced toxicity has received extensive attention. CircRNAs are a class of single-stranded closed-loop molecules that play a regulatory role in the occurrence and development of tumors. An integral role of circRNAs in the development of cancer treatment-induced toxicity, as well as in pathological processes such as oxidative damage, mitochondrial damage, apoptosis, dysregulation of calcium homeostasis, and dysregulation of vascular homeostasis has been deciphered. With regards to chemotherapy, radiotherapy, and immunotherapy for cancer treatment, circRNAs play crucial functions in modulating the effects of oncotherapy-induced toxicity. The current review focuses on the mechanisms by which circRNAs function in regulating cancer treatment-induced toxicity, which leads to apoptosis, mitochondrial damage, oxidative stress, DNA damage, and fibrosis. In addition, this review summarizes the potential circRNA biomarkers, treatment strategies and future challenges, which may help translate circRNA research into clinical practice for early detection and improvement of cancer treatment-induced toxicity in the future.

Indexed as

ChemotherapycircRNAsOncotherapyPrognosisRadiotherapyToxicity

Identifiers

PMID41971016
PMCPMC13068568

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.